home / stock / hema / hema short
Short Information | Hemacare Corp (OTCMKTS:HEMA)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 598,439 |
Total Actual Volume | 1,201,018 |
Short Trends | |
---|---|
Cover Days | 3 |
Short Days | 8 |
No Change Days | 9 |
Averages | |
---|---|
Average Short Volume | 29,922 |
Average Short Percentage | 50.76% |
Is there a HEMA Short Squeeze or Breakout about to happen?
See the HEMA Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
01-03-2020 | $25.31 | $25.31 | $25.31 | $25.31 | 5,455 | 1,000 | 18.33% |
01-02-2020 | $25.20 | $25.16 | $25.21 | $25.14 | 74,523 | 36,063 | 48.39% |
12-31-2019 | $25.17 | $25.20 | $25.25 | $25.165 | 9,985 | 3,145 | 31.5% |
12-30-2019 | $25.20 | $25.15 | $25.24 | $25.15 | 49,336 | 24,604 | 49.87% |
12-27-2019 | $25.20 | $25.29 | $26.23 | $25.16 | 38,018 | 20,361 | 53.56% |
12-26-2019 | $25.15 | $25.15 | $25.17 | $25.15 | 11,414 | 5,344 | 46.82% |
12-24-2019 | $25.17 | $25.15 | $25.20 | $25.10 | 105,707 | 60,007 | 56.77% |
12-23-2019 | $25.15 | $25.19 | $25.20 | $25.14 | 44,509 | 18,574 | 41.73% |
12-20-2019 | $25.15 | $25.17 | $25.19 | $25.14 | 31,908 | 19,934 | 62.47% |
12-19-2019 | $25.19 | $25.15 | $25.20 | $25.10 | 95,220 | 58,107 | 61.02% |
12-18-2019 | $25.10 | $25.19 | $25.25 | $25.09 | 141,148 | 60,404 | 42.79% |
12-17-2019 | $25.06 | $25.10 | $25.12 | $25.06 | 81,316 | 54,866 | 67.47% |
12-16-2019 | $25.00 | $25.08 | $25.10 | $24.90 | 467,988 | 213,016 | 45.52% |
12-12-2019 | $19.40 | $19.80 | $19.80 | $19.10 | 10,495 | 5,148 | 49.05% |
12-10-2019 | $20.00 | $19.80 | $20.00 | $19.33 | 6,050 | 2,480 | 40.99% |
12-09-2019 | $19.95 | $19.80 | $19.95 | $19.80 | 855 | 595 | 69.59% |
12-06-2019 | $19.60 | $19.99 | $19.99 | $19.14 | 12,838 | 10,103 | 78.7% |
12-05-2019 | $19.67 | $19.60 | $19.69 | $19.25 | 850 | 400 | 47.06% |
12-04-2019 | $19.54 | $19.69 | $19.69 | $19.54 | 1,430 | 1,100 | 76.92% |
12-03-2019 | $19.10 | $19.68 | $19.68 | $19.10 | 11,973 | 3,188 | 26.63% |
News, Short Squeeze, Breakout and More Instantly...
– Expands Charles River’s Scientific Capabilities in the High-Growth Cell Therapy Market – – Establishes a Comprehensive Cell Therapy Solution from Discovery through Commercialization – Charles River Laboratories International, Inc. (NYSE: CR...
Advancing cell and gene therapies with the highest quality GMP-compliant bone marrow starting material HemaCare Corporation (OTCMKTS: HEMA), a global leader and trusted brand in the customization of human-derived biological products and services for biomedical research, drug discovery,...
New distribution partnership allows high-quality human primary cells to reach the Chinese market HemaCare Corporation (OTCMKTS: HEMA), a global leader and trusted brand in the customization of human-derived biological products and services for biomedical research, drug discovery, and c...